NCT00266591View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

PHASE3CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

October 31, 1992

Study Completion Date

April 30, 1997

Conditions

EpilepsySeizures

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00266591 - A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy | Biotech Hunter | Biotech Hunter